Corient Private Wealth’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Corient Private Wealth's VCYT Position: Q2 2026 in Review
Corient Private Wealth increased its Veracyte (VCYT) stake by 27% in Q2 2026, buying an estimated $1.44M and bringing the position to 162,021 shares worth $9.52M. The position accounts for 0.01% of the portfolio, ranked #662.
Corient Private Wealth first reported a position in VCYT in Q4 2022 and has held it in 14 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Corient Private Wealth held 162,021 shares of Veracyte worth $9.52M as of Q2 2026.
- Corient Private Wealth bought 34,299 Veracyte shares in Q2 2026, an estimated $1.44M.
- Veracyte made up 0.01% of Corient Private Wealth's portfolio in Q2 2026, its #662 holding.
- Corient Private Wealth first reported a position in Veracyte in Q4 2022 and has held it in 14 quarters since.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.